Search

Your search keyword '"Biaukula, V."' showing total 1 results
Start Over Author "Biaukula, V." Topic antibodies, bacterial

Refine your results

1 results on '"Biaukula, V."'

1. Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Author

Russell FM, Licciardi PV, Balloch A, Biaukula V, Tikoduadua L, Carapetis JR, Nelson J, Jenney AW, Waqatakirewa L, Colquhoun S, Cheung YB, Tang ML, and Mulholland EK

Subjects
Child, Preschool, Heptavalent Pneumococcal Conjugate Vaccine, Humans, Immunoglobulin G blood, Infant, Antibodies, Bacterial blood, Immunization Schedule, Immunization, Secondary methods, Pneumococcal Vaccines adverse effects, Pneumococcal Vaccines immunology
Abstract

Fijian infants aged 6 weeks were stratified by ethnicity and randomized to receive 0, 1, 2, or 3 PCV-7 doses with or without the 23-valent pneumococcal polysaccharide vaccine (PPV-23) at 12 months. Strong booster effects for all 7 PCV-7 serotypes were elicited, and for 4/7 serotypes these responses were highest in the single PCV-7 group. There were fourfold rises in GMC for all non-PCV-7 serotypes. By 17 months the PPV-23 group still had significantly higher GMC (each p<0.001) for all serotypes. The PPV-23 was well tolerated and induced excellent responses for all serotypes which were greatest in the single PCV-7 group., (Copyright 2010 Elsevier Ltd. All rights reserved.)

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results